Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sirolimus for Pachyonychia Congenita
NCT02152007Phase 1Completed
- Sponsor
- TransDerm
- Start
- Jan 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sirolimus in pachyonychia congenita (PC), sponsored by TransDerm. Primary endpoint: Evaluation of Systemic Absorption Through Measurement of Serum Sirolimus Trough Levels. Started Jan 2014; status: completed.
02
Drugs
sirolimus
03
Conditions
pachyonychia congenita (PC)
Beyond the preview
Go deeper on NCT02152007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02152007.